Amarin's Q1 2025 Earnings Call: Contradictions in Global Revenue Trends and U.S. Pricing Pressures

Rest of World revenue trends and expectations, U.S. net price pressures and rebating expectations, Rest of World revenue pacing and expectations, and U.S. market and net price expectations are the key contradictions discussed in Amarin Corporation's latest 2025Q1 earnings call.



Global Expansion and Market Access:
- Amarin Corporation plc expanded its global presence by entering into additional regional partnerships in Southeast Asia, MENA, and Australia.
- This growth was driven by strategic acquisitions and partnerships to expand market access and increase branded revenue in an increasingly genericized market.

European Market Recovery and Growth:
- VASCEPA revenues in Europe showed 16% sequential quarterly growth, with $5.4 million in revenues for Q1 2025.
- The recovery was attributed to focused commercialization efforts, successful market access, and pricing strategies in key markets like Spain, the U.K., and Central Eastern Europe.

U.S. Financial Performance and Brand Maintenance:
- U.S. product revenue was $35.7 million, a decline of 25.4% compared to the previous year due to generic competition and a decrease in volume.
- Despite revenue decline, the U.S. business remained profitable and delivered significant cash, driven by effective management of exclusive accounts and strategic commercial execution.

Rest of World Partnership and Market Development:
- Rest of world revenues were limited to less than $0.1 million for Q1 2025, despite recent launches and partnerships.
- This decline was temporary, and growth is expected due to early-stage commercialization, strong in-market demand, and successful regulatory progress in several regions.